Drug Use and Addiction Research Programs in Delaware
Drug Use and Addiction Research Programs (93.279) awarded $14.0 million to recipients in Delaware in 8 grants from fiscal 2021 to 2025, 0.2% of the program's national total. Astrazeneca Pharmaceuticals LP received the most, $11.3 million.
- Awarded in Delaware$14.0 million
- Awards8
- Share of the program0.2%
- Rank among states42nd of 50
- National total$7.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 4 | $3.6 million |
| FY 2022 | 2 | $2.3 million |
| FY 2023 | 1 | $537,050 |
| FY 2024 | 3 | $3.6 million |
| FY 2025 | 4 | $4.0 million |
Recipients in Delaware
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | Businesses | 2 | $11.3 million |
| University of Delaware | Colleges and universities | 3 | $1.7 million |
| Waybetter, Inc. | Small businesses | 1 | $482,924 |
| Dark Matter Therapeutics, Inc. | Small businesses | 1 | $399,414 |
| Delaware State University | Colleges and universities | 1 | $86,602 |
Open opportunities under this program
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
See all 109 on the program page
Questions people ask
How much Drug Use and Addiction Research Programs money goes to Delaware?
$14.0 million from fiscal 2021 to 2025, across 8 awards. Delaware ranks 42nd of 50 states and territories for this program.
Who receives Drug Use and Addiction Research Programs money in Delaware?
The largest recipient is Astrazeneca Pharmaceuticals LP, with $11.3 million in 2 awards. Next are University of Delaware and Waybetter, Inc..
Can organizations in Delaware apply now?
Yes, 109 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Drug Use and Addiction Research Programs in other states
Other large programs in Delaware
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Clean Energy Demonstrations
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Title I Grants to Local Educational Agencies
- Drinking Water State Revolving Fund
- 1332 State Innovation Waivers
- Special Education Grants to States